Great Lakes Pharmaceuticals, Inc. announces initiation of clinical trial of the catheter lock solution, B-Lock™
10:47 EDT 26 Jul 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
CLEVELAND, July 26, 2012 /PRNewswire-USNewswire/ -- Great Lakes Pharmaceuticals, Inc. announced today the initiation of the clinical study of the first Company product, the antimicrobial lock solution, B-Lock™. The prospective, ...
Other Sources for this Article
More From BioPortfolio on "Great Lakes Pharmaceuticals, Inc. announces initiation of clinical trial of the catheter lock solution, B-Lock™"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
